Promentis Pharmaceuticals
A biopharmaceutical company developing therapiesfor the treatment of central nervous system disorders
1
Funding Rounds
$26.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Ma***** | - | - | - |
| Da*** A. Ba*** | - | - | - |
Funding series
Funding Series Analysis
The company Promentis Pharmaceuticals has raised a total of $26m in funding over 1 rounds.
Key Insights:
- Promentis Pharmaceuticals Series C round, March 2017: $26m
Promentis Pharmaceuticals Series C round, March 2017
$26m
Industries
Promentis Pharmaceuticals is active in the following industries: